The EPS projection of Saia, Inc. (NASDAQ:SAIA) for period quarter completed 2016-12-31 is $0.42.
The EPS estimates pronounced a week and 30 days ago were $0.42 and $0.42 correspondingly. The EPS forecasts specified 60 and 90 days before were $0.42 and $0.42 respectively. From a week ago, the aberration in EPS forecast is -0.01 percent.
The mean EPS prediction straightaway before the earnings release for the quarter completed 2 is $0.42 based on 6 EPS estimations. The EPS stated on 2016-07-29 was $0.52. The EPS surprise was $-0.04, or -7.14 percent. The standard deviation as per known EPS estimates was $0.01.
The positive EPS revisions were 0 a week earlier and negative revisions were 1. In last 30 and 60 days, the positive EPS revisions were 0 and 0 correspondingly, while for 90 and 120 days, revisions count was 0 and 0.
The negative revisions of per-share earnings in the last 30 and 60-days were 1 and 1 in that order. however, for 90 and 120 days’ period, the count was 4 and 5 in that order.
EPS revisions upgrade and downgrade in the last 18 days were 0 and 5 correspondingly.
Quarterly Sales Estimates
The arithmetic mean of probable annual sales of Saia, Inc. (NASDAQ:SAIA) is $308.4 and the median was $308.4. The estimate is stated by 2 analysts for the fiscal 2017.
The highest annual projection is $310.2 and lowest sales target is $306.6. This marks a standard deviation of $2.545.
Almost 2 have given revised positive sales forecast in the past week and 2 have downgraded forecasts. As per the stated estimates, the change in target from the past week is 0 percent.
Nearly 2 have revised sales projections in positive side over the past month and 2 have downgraded forecasts. This shows a mean estimate deviation of 0 percent.
Just about 2 have revised sales forecast on plus side over the quarter and 2 have downgraded forecasts. This shows mean estimate deviation of -0.387 percent.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...